206 related articles for article (PubMed ID: 30149181)
1. Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA.
Di Giovanni G; Chagraoui A; Puginier E; Galati S; De Deurwaerdère P
Neurobiol Dis; 2019 Aug; 128():9-18. PubMed ID: 30149181
[TBL] [Abstract][Full Text] [Related]
2. Effect of l-DOPA on local field potential relationship between the pedunculopontine nucleus and primary motor cortex in a rat model of Parkinson's disease.
Geng X; Wang X; Xie J; Zhang X; Wang X; Hou Y; Lei C; Li M; Han H; Yao X; Zhang Q; Wang M
Behav Brain Res; 2016 Dec; 315():1-9. PubMed ID: 27515286
[TBL] [Abstract][Full Text] [Related]
3. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
Devos D; Defebvre L; Bordet R
Fundam Clin Pharmacol; 2010 Aug; 24(4):407-21. PubMed ID: 20163480
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease.
Navailles S; Carta M; Guthrie M; De Deurwaerdère P
Cent Nerv Syst Agents Med Chem; 2011 Dec; 11(4):305-20. PubMed ID: 22117594
[TBL] [Abstract][Full Text] [Related]
6. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
Li M; Zhou M; Wen P; Wang Q; Yang Y; Xiao H; Xie Z; Li X; Wang N; Wang J; Luo F; Chang J; Zhang W
Exp Neurol; 2016 Aug; 282():27-36. PubMed ID: 27163550
[TBL] [Abstract][Full Text] [Related]
7. Neuronal oscillations of the pedunculopontine nucleus in progressive supranuclear palsy: Influence of levodopa and movement.
Galazky I; Zaehle T; Sweeney-Reed CM; Neumann J; Heinze HJ; Voges J; Kupsch A; Hinrichs H
Clin Neurophysiol; 2020 Feb; 131(2):414-419. PubMed ID: 31877491
[TBL] [Abstract][Full Text] [Related]
8. Levodopa affects spike and local field synchronisation in the pedunculopontine nucleus of a rat model of Parkinson's disease.
Zhang H; Xie J; Li Y; Liu H; Liu C; Kan D; Geng X; Wei S
Aging (Albany NY); 2021 Feb; 13(5):7314-7329. PubMed ID: 33639616
[TBL] [Abstract][Full Text] [Related]
9. Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.
Belaid H; Adrien J; Laffrat E; Tandé D; Karachi C; Grabli D; Arnulf I; Clark SD; Drouot X; Hirsch EC; François C
J Neurosci; 2014 Jul; 34(27):9124-33. PubMed ID: 24990932
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic neurons mediate the anxiolytic effect of l-DOPA: Neuronal correlates in the amygdala.
Faggiani E; Naudet F; Janssen MLF; Temel Y; Benazzouz A
Neurobiol Dis; 2018 Feb; 110():20-28. PubMed ID: 29108985
[TBL] [Abstract][Full Text] [Related]
11. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
[TBL] [Abstract][Full Text] [Related]
12. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
[TBL] [Abstract][Full Text] [Related]
13. The PPN and motor control: Preclinical studies to deep brain stimulation for Parkinson's disease.
Lin C; Ridder MC; Sah P
Front Neural Circuits; 2023; 17():1095441. PubMed ID: 36925563
[TBL] [Abstract][Full Text] [Related]
14. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
Jin X; Schwabe K; Krauss JK; Alam M
Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
[TBL] [Abstract][Full Text] [Related]
15. What can we expect from the serotonergic side of L-DOPA?
De Deurwaerdère P; Navailles S
Rev Neurol (Paris); 2012 Dec; 168(12):927-38. PubMed ID: 22560009
[TBL] [Abstract][Full Text] [Related]
16. L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.
Miguelez C; Navailles S; Delaville C; Marquis L; Lagière M; Benazzouz A; Ugedo L; De Deurwaerdère P
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1297-309. PubMed ID: 27234917
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
Devos D; Bordet R; Defebvre L
Rev Neurol (Paris); 2010 Feb; 166(2):168-77. PubMed ID: 19811797
[TBL] [Abstract][Full Text] [Related]
18. Spike and Local Field Synchronization Between the Pedunculopontine Nucleus and Primary Motor Cortex in a Rat Model of Parkinson's Disease.
Geng X; Wang X; He F; Zhang X; Xie J; Gao G; Han H; Yao X; Zhang H; Gao Y; Wang Y; Wang M
Neuroscience; 2019 Apr; 404():470-483. PubMed ID: 30710670
[TBL] [Abstract][Full Text] [Related]
19. Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.
Karachi C; Francois C
J Neural Transm (Vienna); 2018 Mar; 125(3):471-483. PubMed ID: 28084536
[TBL] [Abstract][Full Text] [Related]
20. Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism.
Masini D; Kiehn O
Nat Commun; 2022 Jan; 13(1):504. PubMed ID: 35082287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
